Very late relapse of Burkitt's lymphoma in an EBV-negative patient after 20 years of complete remission.

B-cell lymphoma Burkitt lymphoma Chemotherapy Recurrence

Journal

Leukemia research reports
ISSN: 2213-0489
Titre abrégé: Leuk Res Rep
Pays: England
ID NLM: 101608906

Informations de publication

Date de publication:
2024
Historique:
received: 29 05 2024
revised: 08 07 2024
accepted: 18 07 2024
medline: 27 8 2024
pubmed: 27 8 2024
entrez: 27 8 2024
Statut: epublish

Résumé

Burkitt's lymphoma (BL) is an aggressive B-cell lymphoma that occurs in children and adults. It is a chemosensitive lymphoma with very exceptional cases of late relapse. We report the case of a 32-year-old male, originally from a nonendemic area for BL, who was successfully treated for abdominal BL 20 years ago. He described a two-month history of cervical swelling and a one-week history of dyspnea. Physical examination was unremarkable except for a left submandibular mass that extended to the collarbone. An ultrasound of the neck revealed cervical lymphadenopathy. The patient was submitted to a lymph node biopsy with an immunohistochemical analysis, which concluded to the diagnosis of BL. Screening for recent Epstein-Barr-Virus (EBV) infection was negative. We considered this a very late relapse (VLR) of the original disease, and the patient was treated according to the same initial protocol. Unfortunately, he suffered a second relapse and died. We report an unusual case of a VLR of nonendemic BL in an EBV-negative patient, occurring 20 years after achieving complete remission following the initial chemotherapy.

Identifiants

pubmed: 39188695
doi: 10.1016/j.lrr.2024.100470
pii: S2213-0489(24)00060-8
pmc: PMC11345915
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

100470

Informations de copyright

© 2024 The Authors. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Auteurs

Kmar Mrad (K)

Hematology Department, Fattouma Bourguiba University Hospital of Monastir, Avenue Farhat Hached, Monastir, 5000, Tunisia.

Nader Slama (N)

Hematology Department, Fattouma Bourguiba University Hospital of Monastir, Avenue Farhat Hached, Monastir, 5000, Tunisia.

Nouha Ben Abdeljalil (N)

Pathology Department, Fattouma Bourguiba University Hospital of Monastir, Avenue Farhat Hached, Monastir, 5000, Tunisia.

Zaineb Mlayah (Z)

Hematology Department, Fattouma Bourguiba University Hospital of Monastir, Avenue Farhat Hached, Monastir, 5000, Tunisia.

Wiem Boufrikha (W)

Hematology Department, Fattouma Bourguiba University Hospital of Monastir, Avenue Farhat Hached, Monastir, 5000, Tunisia.

Abdelfattah Zakhama (A)

Pathology Department, Fattouma Bourguiba University Hospital of Monastir, Avenue Farhat Hached, Monastir, 5000, Tunisia.

Sarra Boukhris (S)

Hematology Department, Fattouma Bourguiba University Hospital of Monastir, Avenue Farhat Hached, Monastir, 5000, Tunisia.

Mohamed Adnene Laatiri (MA)

Hematology Department, Fattouma Bourguiba University Hospital of Monastir, Avenue Farhat Hached, Monastir, 5000, Tunisia.

Classifications MeSH